MODERN VIEW ON THE INTESTINE MICROBIOTA FUCTION AND IT’S CORRECTION IN CHILDREN WITH FOOD ALLERGY



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Представлен обзор данных литературы о роли кишечного биоценоза в патогенезе иммунных нарушений, способствующих развитию пищевой аллергии. Результаты исследований авторов статьи свидетельствуют о целесообразности комплексного подхода к коррекции биоценоза у детей с пищевой аллергий. Показано, что нарушения со стороны кишечной микрофлоры в значительной мере компенсируются без каких-либо специальных вмешательств на фоне элиминационной диеты и адекватной терапии пищевой аллергии. Для дополнительной коррекции дисбиотических отклонений оправдано использование продуктов детского питания, обогащенных про- и пребиотиками. Приведены результаты оценки эффективности гипоаллергенной каши «Помогайка. Рис с плодами рожкового дерева» в питании детей с атопическим дерматитом и детей из группы риска по развитию аллергической патологии.

Full Text

Restricted Access

About the authors

S G Makarova

Scientific Center of Children’s Health RAMS

Moscow, Russia

T A Borovic

Scientific Center of Children’s Health RAMS; First Moscow State Medical University named after I.M. Setchenov

Email: borovik@nczd.ru
Moscow, Russia

I I Balabolkin

Scientific Center of Children’s Health RAMS

Moscow, Russia

L K Katosova

Scientific Center of Children’s Health RAMS

Moscow, Russia

O L Lukoyanova

Scientific Center of Children’s Health RAMS

Moscow, Russia

N N Semenova

Scientific Center of Children’s Health RAMS

Moscow, Russia

T N Stepanova

Scientific Center of Children’s Health RAMS

Moscow, Russia

References

  1. Asher M.I., Montefort S., Bjorksten B. et al. Worldwide trends in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phase One and Three repeat multicountry cross-sectional surveys. Lancet. 2006, v. 368, p. 733-743.
  2. Prescott S., Allen K.J. Food allergy: riding the second wave of allergy epidemic. Pediatric Allergy and Immunolog. 2011, v. 22, Issue 1, p. 156-160.
  3. Намазова-Баранова Л.С. Аллергия у детей: от теории — к практике. М., Союз педиатров России. 2010—2011, 667 с.
  4. Robertson C.F., Roberts M.F., Kappers J.H. Asthma prevalence in Melburne schoolchildren: have we reached the peak? Med. J. Austr. 2004, v. 180, p. 273-276.
  5. Waterland R.A., Mishels K.B. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 2007, v. 27, p. 363-388.
  6. Prescott S.L., Breckler L.A., Witt C.S. et al. Allergic women show reduced T helper type 1 alloresponses to fetal human leucocyte antigen mismatch during pregnancy. Clin. Exp. Immunol. 2010, v. 159, p. 65-72.
  7. Strachan D.P. Hay fever, hygiene, and household size. BMJ. 1989, v. 299, p. 1259-1260.
  8. Strachan D.P. Family size, infection and atopy: the first decade of the «hyhiene hypothesis». Thorax. 2000, v. 5 (Suppl. 1), p. 52-59.
  9. El-Zein M., Parent M.E., Benedetti A., Rousseau M.C. Does BCG vaccination protect against the development of childhoodasthma? A systematic review andmeta-analysis of epidemiological studies. Int. J. Epidemiol. 2010, v. 39, p. 469-486.
  10. Ramsey C.D., Celedon J.C. The hygienehypothesis and asthma. Curr. Opin. Pulm. Med. 2005, v. 11, p. 14-20.
  11. Linneberg A., Ostergaard C., Tvede M. et al. IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study. J. Allergy Clin. Immunol. 2003, v. 111, p. 847-853.
  12. Rennie D.C., Lawson J.A., Kirychuk S.P. et al. Assessment of endotoxin levels in the home and current asthma and wheezing school-age children. Indoor. Air. 2008, v. 18, p. 447-453.
  13. Dahl M.E., Dabbagh K., Liggitt D. et al. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat. Immunol. 2004, v. 5, p. 337-343.
  14. Silverberg J.I., Kleiman E., Silverberg N. et al. B. Chickenpox in childhood is associated with decreased atopic disorders, IgE, allergic sensitization, and leukocyte subset/ Pediatric Allergy and Immunolog. V. 23, Issue 1, p. 50-58.
  15. Araujo M.I., Hoppe B., Medeiros M. Jr. et al. Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J. Infect. Dis. 2004, v. 190, p. 1797-1803.
  16. Von Mutius E., Braun-Fahrlander C., Schierl R. et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin. Exp. Allergy. 2000, v. 30, p. 1230-1234.
  17. Debarry J., Garn H., Hanuszkiewicz A. et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J. Allergy Clin. Immunol. 2007, v. 119, p.1514-1521.
  18. Ege M.J., Bieli C., Frei R. et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J. Allergy Clin. Immunol. 2006, v. 117, p. 817-823.
  19. Roduit C., Wohlgensinger J., Frei R. et al. Prenatal animal contact and gene expression of innate immunity receptors at birth are associated with atopic dermatitis. J. Allergy Clin. Immunol. 2011, v. 127, p. 179-185.
  20. Ege M.J., Mayer M., Normand A.C. et al. Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med. 2011, v. 364, p. 701-709.
  21. Feng T, Elson C.O. Adaptive immunity in the host-microbiota dialog. Mucosal Immunol. 2011, v. 4, p. 15-21.
  22. Atarashi K., Tanoue T., Shima T et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011, v. 331, p. 337-341.
  23. Lyons A., O’Mahony D., O’Brien F. et al. Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin. Exp. Allergy. 2010, v. 40, p. 811-819.
  24. Karimi K., Inman M.D., Bienenstock J., Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. Care Med. 2009, v. 179, p. 186-193.
  25. Lyons A., O'Mahony D., O'Brien F. et al. Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin. Exp. Allergy. 2010, v. 40 (5), p. 811-819.
  26. Zhang L.L., Chen X., Zheng P.Y. et al. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J. Gastroenterol Hepatol. 2010, v. 25 (5), p. 928-934.
  27. Schouten B., van Esch B.C., Hofman G.A. et al. Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J. Nutr. 2009, v. 139 (7), p. 1398-1403.
  28. Schiavi E., Barletta B., Butteroni C. et al. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy. 2011, v. 66, No. 4, p. 499-508.
  29. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008, v. 453, p. 620-625.
  30. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation ofthe host immune system. Cell. 2005, v. 122, p. 107-118.
  31. Niebuhr M., Kopfnagel V., Dittrich-Breiholz O. et al. Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal α-toxin Allergy. 2012, v. 67, Issue 1, p. 41-49.
  32. Ghadimi D., Fölster-Holst R., de Vrese M. et al. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Allergy. 2011, v. 66, No. 4, p. 499.
  33. Johannsen H., Prescott S.L. Practical prebiotics, probiotics and symbiotic for allergists: how useful are they? Clin. Exp. Allergy. 2009, v. 39, p. 1801-1814.
  34. Schrezenmeir J., de Vrese M. Probiotics, prebiotics, and synbiotics—approaching a definition. Am. J. Clin. Nutr. 2001, v. 2 (Suppl), p. 361-364.
  35. Cummings J.H., Macfarlane G.T. Gastrointestinal effects of prebiotics. Br. J. Nutr. 2002, v. 87 (Suppl 2), p. 145-151.
  36. Rao S., Srinivasjois R., Patole S. Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch. Pediatr. Adolesc. Med. 2009, v. 163, p. 755-764.
  37. Sela D.A., Chapman J., Adeuya A. et al. The genome sequence of Bifidobacterium longum subsp.infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. USA. 2008, v. 105, p. 18964-18969.
  38. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 2003, v. 62, p. 67-72.
  39. Russell D.A., Ross R.P., Fitzgerald G.F., Stanton C. Metabolic activities and probiotic potential of bifidobacteria. Int. J. Food. Microbiol. 2011, v. 149, p. 88-105.
  40. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nat. Immunol. 2011, v. 12, p. 5-9.
  41. Hennessy A.A., Ross R.P., Devery R., Stanton C. Optimization of a reconstituted skim milk based medium for enhanced CLA production by bifidobacteria. J. Appl. Microbiol. 2009, v. 106, p. 1315-1327.
  42. O’Shea E.F., Cotter P.D., Stanton C. et al. Production ofbio-active substancesby intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid. Int. J. Food Microbiol. 2012, v. 152, p. 189-205.
  43. Frei1 R., Lauener R.P. Crameri R.& O’Mahony L. Microbiota and dietary interactions — an update to the hygiene hypothesis? Allergy. 2012, v. 67, p. 451-461.
  44. Roberfroid M.B. Concepts in Functional Foods: The Case of Inulin and Oligofructose. J. Nutr. 2007, v. 137, p. 2709-2716.
  45. Muller I., Jenner J., Handgretinger R., Riberdy J., Kerst G. Glycosylation and lectins-examples of immunesurveillance andimmune evasion. Histol Histopathol. 2004, v. 19, p. 527-533.
  46. Drickamer K. Two distinct classes of carbohydrate-recogni-tion domains in animal lectins. J. Biol. Chem. 1988, v. 263, p. 9557-9560.
  47. Van Kooyk Y., Rabinovich G.A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 2008, v. 9, p. 593-601.
  48. Rabinovich G.A., Toscano M.A. Turning'sweet’ on immunity: galectin-glycan interactionsin immune tolerance and inflammation. Nat. Rev. Immunol. 2009, v. 9, p. 338-352.
  49. Erbacher A., Gieseke F., Handgretinger R.,Muller I. Dendritic cells: functional aspectsof glycosylation and lectins. Hum. Immunol. 2009, v. 70, p. 308-312.
  50. Svajger U., Anderluh M., Jeras M., Obermajer N. C-type lectin DC-SIGN: anadhesion, signalling and antigen-uptake molecule that guides dendritic cells inimmunity. Cell Signal. 2010, v. 22, p. 1397-1405.
  51. Van Kooyk Y C-type lectins on dendriticcells: key modulators for the induction ofimmune responses. Biochem Soc. Trans. 2008, v. 6, p. 1478-1481.
  52. De Kivit S., Kraneveld A.D., Garssen J., Willemsen L.E. Glycan recognition at the interface of the intestinal immune system: target for immune modulation via dietary components. Eur. J. Pharmacol. 2011, v. 668, p. 124-132.
  53. Tang M.L.Probiotics and prebiotics: immunological and clinical effects in allergic disease. Nestle Nutr. Workshop Ser. Pediatr. Program. 2009, v. 64, p. 219-235; discussion 235-8, 251-7. Epub. 2009 Aug 19.
  54. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J. et al. Probiotics for treating eczema. Cochrane Database Syst. Rev. 2008, v. 8 (4), CD006135.
  55. Van der Aa L.B., Heymans H.S., van Aalderen W.M., Sprikkelman A.B. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr. Allergy Immunol. 2010, v. 21 (2 Pt 2), p. 355-367.
  56. Lahtinen S.J., Boyle R.J., Kivivuori S. et al. Prenatal administration of Lactobacillus ramnosus has no effect on the diversity of the early infants gut microbiota. Pediatric. allergy and immunology. 2012, v. 23, No. 3, p. 255-258.
  57. Ismail I.H. Oppedisano F., Joseph S.J. et al. Prenatal administration of Lactobacillus ramnosus has no effect on the diversity of the early infants gut microbiota. Pediatric. allergy and immunology. 2012, v. 23, No. 3, p. 255-258.
  58. Boyle R.J., Ismail I. H. Kivivuori S. et al. Lactobacillus LGG treatment during pregnancy for the prevention of ecxema: a randomized control trial. Allergy. 2011, v. 66, No. 4, p. 509-616.
  59. Ismail I.H. Oppedisano F., Joseph S.J. et al. Prenatal administration of Lactobacillus ramnosus has no effect on the diversity of the early infants gut microbiota Pediatric allergy and immunology. 2012, v. 23, No. 3, p. 255-258.
  60. Martin R., Langa S., Reviriego C., Jiménez E., Marin M.L., et al. Rodriguez J.M. Human milk is a source of lactic acid bacteria for the infant gut. J. Pediatr. 2003, v. 143, p. 754-758.
  61. Gueimonde M., Laitinen K., Salminen S., Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology. 2007, v. 92, p. 64-66.
  62. Martin R., Heilig H.G., Zoetendal E.G. et al. Cultivationin-dependent assessment of the bacterial diversity of breast milk among healthy women. Res. Microbiol. 2007, v. 158, p. 31-37.
  63. Martin R., Heilig H.G., Zoetendal E.G. et al. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J. Appl. Microbiol. 2007, v. 103, p. 2638-2644.
  64. Kalliomäki M., Kujavainen P., Eerola E. et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001, v. 107 (1), p. 129-134.
  65. Björkstén B., Sepp E., Julge K. et al. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001, v. 108 (4), p. 516-520.
  66. Songjinda P., Nakayama J., Tateyama A. et al. Differences in developing intestinal microbiota between allergic and non-allergic infants: a pilot study in Japan. Biosci. Biotechnol Biochem. 2007, v. 71 (9), p. 2338-2342.
  67. Thompson-Chagoyan O.C., Vieites J.M., Maldonado J. et al. Changes in faecal microbiota of infants with cow's milk protein allergy. Spanish prospective case-control 6-month follow-up study. Pediatr. Allergy Immunol. 2010, v. 21 (2 Pt 2), p. 394-400.
  68. Макарова С.Г. Обоснование и оценка эффективности диетотерапии при пищевой аллергии у детей в различные возрастные периоды. Диссертация д-ра мед. наук. М., 2008, 369 с.
  69. Макарова С.Г., Боровик Т.Э., Балаболкин И.И. и соавт. Состояние кишечного микробиоценоза у детей с атопическим дерматитом в зависимости от особенностей клинической картины и формы заболевания. Педиатрия. 1997, № 2, с. 19-24.
  70. Макарова С.Г. Диетическая коррекция дисбактериоза кишечника при пищевой аллергии у детей раннего возраста Диссертация канд. мед. наук. М., 1992, 105 с.
  71. Макарова С.Г., Боровик Т.Э. Дисбиоз кишечника у детей с пищевой аллергией: патогенетические аспекты и современные методы коррекции. Вопр. совр. педиатрии. 2008, т. 7, № 2, с. 82-92.
  72. Isolauri E., Salminen S., Ouwehand A.C. Microbial-gut interactions in health and disease. Probiotics. Best Pract. Res. Clin. Gastroenterol. 2004, v. 18, p. 299-313.
  73. Боровик Т.Э., Ладодо К.С., Куваева И.Б., Макарова С.Г. Состояние кишечной микрофлоры у детей с пищевой аллергией на фоне диетотерапии. Рос. журн. гастроэнтерол., гепатол., колопроктол. М., 1995, т. 3, № 3, c. 147.
  74. Bruni F.M., Piacentini G.L., Peroni D.G. et al. Cow's milk allergic children can present sensitisation to probiotics. Acta Paediatr. 2009, v. 98 (2), p. 321-323.
  75. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J. et al. Probiotics for treating eczema. Cochrane Database Syst. Rev. 2008, v. 8 (4), CD006135.
  76. Боровик Т.Э., Балаболкин И.И., Макарова С.Г. и соавт. Использование продуктов, способствующих нормализации кишечного биоценоза, при пищевой аллергии у детей раннего возраста. Аллергология. 2001, № 1, с. 29-33.
  77. Макарова С.Г., Боровик Т.Э., Балаболкин И.И. Роль диетотерапии в коррекции дисбиотических нарушений у детей раннего возраста с атопическим дерматитом, обусловленным пищевой сенсибилизацией. Вопр. детской диетол. 2003, № 1, с. 34-38.
  78. West C.E., Hammarström M.L., Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr. Allergy Immunol. 2009, v. 20 (5), p. 430-437.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2012



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies